Treatment of bipolar disorder

The Lancet

Volumn 381, Issue 9878, 2013, Pages 1672-1682

  Geddes, John R ^a   Miklowitz, David J ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; CHLORPROMAZINE; FLUOXETINE PLUS OLANZAPINE; HALOPERIDOL; KETAMINE; LAMOTRIGINE; LITHIUM; LURASIDONE; MODAFINIL; OLANZAPINE; PAROXETINE; PLACEBO; PRAMIPEXOLE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CIRCADIAN RHYTHM; COGNITIVE THERAPY; COMPARATIVE STUDY; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR DEPRESSION; MANIA; MENTAL INSTABILITY; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RELAPSE; RISK; SEDATION; SHORT COURSE THERAPY; SIDE EFFECT; SUICIDE; WEIGHT GAIN;

EID: 84877709911     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)60857-0     Document Type: Review

References (105)

1. KR Merikangas, HS Akiskal, J Angst et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication Arch Gen Psychiatry 64 2007 543 552
2. KR Merikangas, R Jin, JP He et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative Arch Gen Psychiatry 68 2011 241 251
3. MJ Gitlin, J Swendsen, TL Heller, C Hammen Relapse and impairment in bipolar disorder Am J Psychiatry 152 1995 1635 1640
4. RH Perlis, MJ Ostacher, JK Patel et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Am J Psychiatry 163 2006 217 224
5. LL Judd, HS Akiskal, PJ Schettler et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder Arch Gen Psychiatry 59 2002 530 537
6. SC Dilsaver An estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009 J Affect Disord 129 2011 79 83
7. LL Judd, HS Akiskal, PJ Schettler et al. Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study Arch Gen Psychiatry 62 2005 1322 1330
8. E Michalak, JD Livingston, R Hole, M Suto, S Hale, C Haddock 'It's something that I manage but it is not who I am': reflections on internalized stigma in individuals with bipolar disorder Chronic Illn 7 2011 209 224
9. A Cipriani, C Barbui, G Salanti et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis Lancet 378 2011 1306 1315
10. DA Cousins, K Butts, AH Young The role of dopamine in bipolar disorder Bipolar Disord 11 2009 787 806
11. CA Stockmeier Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter J Psychiatr Res 37 2003 357 373
12. N Diazgranados, L Ibrahim, NE Brutsche et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression Arch Gen Psychiatry 67 2010 793 802
13. CA Zarate Jr, NE Brutsche, L Ibrahim et al. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial Biol Psychiatry 71 2012 939 946
14. X Li, MA Frye, RC Shelton Review of pharmacological treatment in mood disorders and future directions for drug development Neuropsychopharmacol 37 2012 77 101
15. AJ Harwood Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited Mol Psychiatry 10 2005 117 126
16. G Agam, A Shamir, G Shaltiel, ML Greenberg Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs Bipolar Disord 4 suppl 1 2002 15 20
17. AC Andreazza, LT Young The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment Int J Neuropsychopharmacol 1 2013 1 14
18. AR Newberg, LA Catapano, CA Zarate, HK Manji Neurobiology of bipolar disorder Expert Rev Neurother 8 2008 93 110
19. SM Strakowski, CM Adler, J Almeida et al. The functional neuroanatomy of bipolar disorder: a consensus model Bipolar Disord 14 2012 313 325
20. AG Harvey Sleep and circadian functioning: critical mechanisms in the mood disorders? Ann Rev Clin Psychol 7 2011 297 319
21. E Frank, DJ Kupfer, ME Thase et al. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder Arch Gen Psychiatry 62 2005 996 1004
22. S Malkoff-Schwartz, E Frank, B Anderson et al. Stressful life events and social rhythm disruption in the onset of manic and depressive bipolar episodes: a preliminary investigation Arch Gen Psychiatry 55 1998 702 707
23. DJ Miklowitz, SL Johnson Social and familial risk factors in bipolar disorder: basic processes and relevant interventions Clin Psychol Sci Pract 16 2009 281 296
24. SL Johnson, A Cuellar, C Ruggero et al. Life events as predictors of mania and depression in bipolar I disorder J Abnorm Psychol 117 2008 268 277
25. JM Hooley Expressed emotion and relapse of psychopathology Ann Rev Clin Psychol 3 2007 329 352
26. TL Simoneau, DJ Miklowitz, JA Richards, R Saleem, EL George Bipolar disorder and family communication: effects of a psychoeducational treatment program J Abnorm Psychol 108 1999 588 597
27. SM Strakowski, PE Keck, SL McElroy et al. Twelve-month outcome after a first hospitalization for affective psychosis Arch Gen Psychiatry 55 1998 49 55
28. DJ Miklowitz, EL George, JA Richards, TL Simoneau, RL Suddath A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder Arch Gen Psychiatry 60 2003 904 912
29. F Colom, E Vieta, A Martinez-Aran et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of bipolar disorder: a five year follow-up Br J Psychiatry 194 2009 260 265
30. LN Yatham, SH Kennedy, SV Parikh et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013 Bipolar Disord 15 2013 1 44
31. HJ Gijsman, JR Geddes, JM Rendell, WA Nolen, GM Goodwin Antidepressants for bipolar depression: a systematic review of randomised controlled trials Am J Psychiatry 161 2004 1537 1547
32. MA Frye, K Ha, S Kanba et al. International consensus group on depression prevention in bipolar disorder J Clin Psychiatry 72 2011 1295 1310
33. GS Sachs, AA Nierenberg, JR Calabrese et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression N Engl J Med 356 2007 1711 1722
34. SL McElroy, RH Weisler, W Chang et al. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II) J Clin Psychiatry 71 2010 163 174
35. MM Sidor, GM MacQueen An update on antidepressant use in bipolar depression Curr Psychiatry Rep 14 2012 696 704
36. A Cipriani, TA Furukawa, G Salanti et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis Lancet 373 2009 746 758
37. RH Weisler, JR Calabrese, CL Bowden, JA Ascher, J DeVeaugh-Geiss, G Evoniuk Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence J Affect Disord 108 2008 1 9
38. JR Geddes, JR Calabrese, GM Goodwin Lamotrigine for treatment of bipolar depression: an independent meta-analysis and meta-regression of individual patient data from five randomised trials Br J Psychiatry 194 2009 4 9
39. J De Fruyt, E Deschepper, K Audenaert et al. Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis J Psychopharmacol 26 2012 603 617
40. RH Weisler, WA Nolen, A Neijber, A Hellqvist, B Paulsson Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study) J Clin Psychiatry 72 2011 1452 1464
41. M Tohen, E Vieta, J Calabrese et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression Arch Gen Psychiatry 60 2003 1079 1088
42. A Loebel, J Cucchiaro, R Silva et al. Lurasidone monotherapy for the treatment of bipolar I depression: results of a 6-week, double-blind, placebo-controlled study 2012 American Psychiatric Association Philadelphia, PA
43. RH Weisler, SA Montgomery, WR Earley, J Szamosi, A Lazarus Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies Int Clin Psychopharmacol 27 2012 27 39
44. LL Judd, HS Akiskal, PJ Schettler et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder Arch Gen Psychiatry 60 2003 261 269
45. LL Altshuler, RM Post, DO Black et al. Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study J Clin Psychiatry 67 2006 1551 1560
46. LM Weinstock, IW Miller Functional impairment as a predictor of short-term symptom course in bipolar I disorder Bipolar Disord 10 2008 437 442
47. LM Weinstock, IW Miller Psychosocial predictors of mood symptoms 1 year after acute phase treatment of bipolar I disorder Comp Psychiatry 51 2010 497 503
48. P Sienaert, L Lambrichts, A Dols, FJ De Evidence-based treatment strategies for treatment-resistant bipolar depression: a systematic review Bipolar Disord 15 2013 61 69
49. JFJ Cade Lithium salts in the treatment of psychotic excitement Med J Aust 36 1949 349 352
50. JR Geddes, S Burgess, K Hawton, K Jamison, GM Goodwin Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials Am J Psychiatry 161 2004 217 222
51. A Cipriani, H Pretty, K Hawton, JR Geddes Lithium in the prevention of suicidal behaviour and all-cause mortality in patients with mood disorders: a systematic review of randomised trials Am J Psychiatry 162 2005 1805 1819
52. RF McKnight, M Adida, K Budge, S Stockton, GM Goodwin, JR Geddes Lithium toxicity profile: a systematic review and meta-analysis Lancet 379 2012 721 728
53. GM Goodwin, CL Bowden, JR Calabrese et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder J Clin Psychiatry 65 2004 432 441
54. J Hayes, P Prah, I Nazareth et al. Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009 PLoS One 6 2011 e28725
55. KA Macritchie, JR Geddes, J Scott, DR Haslam, GM Goodwin Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder Cochrane Database Syst Rev 3 2001 CD003196
56. JR Geddes, GM Goodwin, J Rendell et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial Lancet 375 2010 385 395
57. GM Goodwin Consensus Group of the British Association for Psychopharmacology Evidence-based guidelines for treating bipolar disorder: Revised second edition - recommendations from the British Association for Psychopharmacology J Psychopharmacol 23 2009 346 388
58. LV Kessing, HV Hansen, A Hvenegaard et al. Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the early course of bipolar disorder: randomised clinical trial Br J Psychiatr 202 2013 212 219
59. DJ Miklowitz, J Scott Psychosocial treatments for bipolar disorder: Cost-effectiveness, mediating mechanisms, and future directions Bipolar Disord 11 2009 110 122
60. DJ Miklowitz, MW Otto, E Frank et al. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program Arch Gen Psychiatry 64 2007 419 427
61. DJ Miklowitz, MW Otto, E Frank et al. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial Am J Psychiatry 164 2007 1 8
62. JF Clarkin, D Carpenter, J Hull, P Wilner, I Glick Effects of psychoeducational intervention for married patients with bipolar disorder and their spouses Psychiatr Serv 49 1998 531 533
63. MM Rea, MC Tompson, DJ Miklowitz, MJ Goldstein, S Hwang, J Mintz Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial J Consult Clin Psychol 71 2003 482 492
64. DJ Miklowitz, DA Axelson, B Birmaher et al. Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial Arch Gen Psychiatry 65 2008 1053 1061
65. DJ Miklowitz, CD Schneck, MK Singh et al. Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy J Am Acad Child Adol Psychiatry 52 2013 121 131
66. D Perlick, DJ Miklowitz, N Lopez et al. Family-focused treatment for caregivers of patients with bipolar disorder Bipolar Disord 12 2010 627 637
67. IW Miller, GI Keitner, CE Ryan, LA Uebelacker, SL Johnson, DA Solomon Family treatment for bipolar disorder: family impairment by treatment interactions J Clin Psychiatry 69 2008 732 740
68. M Reinares, F Colom, J Sánchez-Moreno et al. Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial Bipolar Disord 10 2008 511 519
69. MA Fristad, JS Verducci, K Walters, ME Young Impact of multifamily psychoeducational psychotherapy in treating children aged 8 to 12 years with mood disorders Arch Gen Psychiatry 66 2009 1013 1021
70. SD Cochran Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders J Cons Clin Psychol 52 1984 873 878
71. DH Lam, P Hayward, ER Watkins, K Wright, P Sham Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years Am J Psychiatry 162 2005 324 329
72. JR Ball, PB Mitchell, JC Corry, A Skillecorn, M Smith, GS Malhi A randomized controlled trial of cognitive therapy for bipolar disorder: focus on long-term change J Clin Psychiatry 67 2006 277 286
73. J Scott, E Paykel, R Morriss et al. Cognitive behaviour therapy for severe and recurrent bipolar disorders: a randomised controlled trial Br J Psychiatry 188 2006 313 320
74. A Zaretsky, W Lancee, C Miller, A Harris, SV Parikh Is cognitive-behavioural therapy more effective than psychoeducation in bipolar disorder? Can J Psychiatry 53 2008 441 448
75. SV Parikh, A Zaretsky, S Beaulieu et al. A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study J Clin Psychiatry 73 2012 803 810
76. TD Meyer, M Hautzinger Cognitive behaviour therapy and supportive therapy for bipolar disorders: relapse rates for treatment period and 2-year follow-up Psychol Med 42 2012 1429 1439
77. HA Swartz, E Frank, Y Cheng A randomized pilot study of psychotherapy and quetiapine for the acute treatment of bipolar II depression Bipolar Disord 14 2012 211 216
78. F Colom, E Vieta, A Martinez-Aran et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission Arch Gen Psychiatry 60 2003 402 407
79. C Torrent, C del Mar Bonnin, A Martinez-Aran et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study Am J Psychiatry 2013 10.1176/appi.ajp.2012.12070971 published online March 20.
80. RD Weiss, ML Griffin, ME Kolodziej et al. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence Am J Psychiatry 164 2007 100 107
81. A Perry, N Tarrier, R Morriss, E McCarthy, K Limb Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment BMJ 318 1999 149 153
82. GE Simon, EJ Ludman, MS Bauer, J Unutzer, B Operskalski Long-term effectiveness and cost of a systematic care program for bipolar disorder Arch Gen Psychiatry 63 2006 500 508
83. MS Bauer, L McBride, WO Williford et al. Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs Psychiatr Serv 57 2006 937 945
84. DJ Miklowitz, GM Goodwin, M Bauer, JR Geddes Common and specific elements of psychosocial treatments for bipolar disorder: a survey of clinicians participating in randomized trials J Psychiatr Pract 14 2008 77 85
85. IM Anderson, PM Haddad, J Scott Bipolar disorder BMJ 345 2012 e8508
86. DJ Miklowitz Adjunctive psychotherapy for bipolar disorder: state of the evidence Am J Psychiatry 165 2008 1408 1419
87. J Scott, FEV Colom A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders Int J Neuropsychopharmacol 10 2007 123 129
88. DH Lam, R Burbeck, K Wright, S Pilling Psychological therapies in bipolar disorder: the effect of illness history on relapse prevention - a systematic review Bipolar Disord 11 2009 474 482
89. DJ Miklowitz Bipolar disorder: a family-focused treatment approach 2nd ed. 2008 Guilford Press New York
90. AT Beck, AJ Rush, BF Shaw, G Emery Cognitive therapy of depression 1987 Guilford Press New York
91. F Benedetti, A Serretti, C Colombo et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression Am J Med Gen B: Neuropsychiatr Gen 123 2003 23 26
92. K Roybal, D Theobold, A Graham et al. Mania-like behavior induced by disruption of CLOCK Proc Natl Acad Sci USA 104 2007 6406 6411
93. J Scott, F Colom, E Popova et al. Long-term mental health resource utilization and cost of care following group psychoeducation or unstructured group support for bipolar disorders: a cost-benefit analysis J Clin Psychiatry 70 2009 378 386
94. M Grskovic, A Javaherian, B Strulovici, GQ Daley Induced pluripotent stem cells - opportunities for disease modelling and drug discovery Nat Rev Drug Discov 10 2011 915 929
95. Cross-Disorder Group of the Psychiatric Genomics Consortium Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis Lancet 2013 10.1016/S0140-6736(12)62129-1 published online Feb 27.
96. CH Arrowsmith, C Bountra, PV Fish, K Lee, M Schapira Epigenetic protein families: a new frontier for drug discovery Nat Rev Drug Discov 11 2012 384 400
97. KM Tye, K Deisseroth Optogenetic investigation of neural circuits underlying brain disease in animal models Nat Rev Neurosci 13 2012 251 266
98. N Singh, AC Halliday, JM Thomas et al. A safe lithium mimetic for bipolar disorder Nat Commun 4 2013 1332
99. AJ Gelenberg, ME Thase, RE Meyer et al. The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies J Clin Psychiatry 69 2008 1513 1528
100. JM Bopp, DJ Miklowitz, GM Goodwin, W Stevens, JM Rendell, JR Geddes The longitudinal course of bipolar disorder as revealed through weekly text-messaging Bipolar Disord 12 2010 327 334
101. DJ Miklowitz, J Price, EA Holmes et al. Facilitated integrated mood management (FIMM) for adults with bipolar disorder Bipolar Disord 14 2012 185 197
102. SD Hollon, RF Muñoz, DH Barlow et al. Psychosocial intervention development for the prevention and treatment of depression: Promoting innovation and increasing access Biol Psychiatr 52 2002 610 630
103. EA Holmes, JR Geddes, F Colom, GM Goodwin Mental imagery as an emotional amplifier: Application to bipolar disorder Behav Res Ther 46 2008 1251 1258
104. ML Phillips, MJ Kupfer Bipolar disorder diagnosis: challenges and future directions Lancet 381 2013 1663 1671
105. B Birmaher, D Axelson, B Goldstein et al. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study Am J Psychiatry 166 2009 795 804